Table 2. Three methods for evaluating satisfaction after 12 and 24 months in nanofat and control group patents (cases, %).
| Evaluators | n | I | II | III | V |
|---|---|---|---|---|---|
| 12 months | |||||
| A | 62 vs | 50 (80.65)vs | 7 (11.29)vs | 2 (3.23)vs | 3 (4.83)vs |
| 77 | 31 (40.26) | 21 (27.27) | 15 (19.48) | 10 (12.99) | |
| B | 62vs | 54 (87.10)vs | 5 (8.06)vs | 1 (1.61)vs | 2 (3.23)vs |
| 77 | 34 (44.16) | 23 (29.87) | 13 (16.88) | 7 (9.09) | |
| C | 62vs | 48 (77.42)vs | 8 (12.90)vs | 2 (3.23)vs | 4 (6.45)vs |
| 77 | 32 (41.56) | 19 (24.68) | 15 (19.48) | 11 (14.28) | |
| 24 months | |||||
| A | 47vs | 38 (80.85)vs | 4 (8.51)vs | 2 (4.26)vs | 3 (6.38)vs |
| 58 | 23 (39.66) | 16 (27.59) | 11 (18.96) | 8 (13.79) | |
| B | 47vs | 40 (85.11)vs | 3 (6.38)vs | 1 (2.13)vs | 3 (6.38)vs |
| 58 | 25 (43.10) | 17 (29.31) | 12 (20.69 | 4 (6.90) | |
| C | 47vs | 36 (76.60)vs | 6 (12.77)vs | 3 (6.38)vs | 2 (4.26)vs |
| 58 | 23 (39.66) | 15 (25.86) | 15 (25.86 | 5 (8.62) | |
A, patients; B, surgeons; C, entrusted assessment
I, very satisfied; II, satisfied; III, average; IV, unsatisfied